Breakthrough scientists often lack the capital, lab space, and operational support to build companies where they are—while VCs miss out on high-potential opportunities, often due to limited ties with universities.

We give top innovators in emerging ecosystems a clear path to build and fund their companies.

First, we provide what’s scarce: early-stage capital, fully equipped lab space, and access to a global network built by founders who’ve taken startups public and raised $750M+.

Second, we leverage deep university relationships to identify top technologies early, attracting investors and corporate partners into these emerging markets.

Third, our in-house scientific team supports portfolio companies across strategy, data, and commercialization to accelerate growth.